Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...
UNIONDALE, NY / ACCESS Newswire / January 7, 2026 / Marquis Who's Who, the trusted biographical authority documenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback